Amgen (AMGN) ROE - Return on Equity

Current and historical Return on Equity (ROE) values for Amgen (AMGN) over the last 10 years.

Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $130.519B $22.991B
Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives.